-
MLB proposes shortening season, reforming playoffs
-
Swiss captain Xhaka gets suspended fine for fake Covid cert
-
Crew splashes down after 8-month mission on International Space Station
-
Ex-prince Andrew raid warrants ruled 'unlawful' but UK police maintain probe
-
Protests, clashes as S. African anti-migrant tensions reignite
-
Two Latvians arrested inside UK military base: police
-
Russian data centre hit by drone in first for Ukraine war
-
Eckert 'forever grateful' for Southampton support over spy scandal
-
'Fighting for our future': France high school students vow no let-up
-
Venezuela's Maduro, wife hit with new US torture charges
-
Kyiv entering 'survival' mode amid Russian strikes surge: mayor tells AFP
-
Argentina friendlies no fairy tale for African footballers
-
Verdict due in Mexico trial over murders of Australia, US surfers
-
US suspending Microsoft from visa program: Vance
-
B2PRIME Welcomes Christina Barbash as Commercial Manager
-
Man City must 'stick together' during crisis, says Haaland
-
Russia forcing Kyiv into 'survival' mode before winter, mayor tells AFP
-
CAS opens hearing into Senegal AFCON title appeal
-
Closing arguments begin in Maradona death trial
-
UK police agree searches for ex-prince Andrew's homes 'unlawful': judge
-
UEFA president Ceferin to stand for re-election in 2027
-
After botched US execution, Christa Pike walking, mentally 'foggy': lawyer
-
Nearly 300,000 Nepalis at flood risk: study
-
'Stunned' Madrid mourns pensioner who sparked housing protests
-
Riyadh kindergarten hit by interception debris as Houthis say targeted airport
-
High school students turn out for new protests across France
-
Alex Bodi mizează, alături de CRIF, pe investiții transparente și pe prevenirea riguroasă a spălării banilor
-
Bid by Italy's Intesa bank to take over MPS gets boost
-
Gulf Labs, Part of Thailand’s $27 Billion GULF Group, Goes Live as an Injective Validator
-
Stablecoins Are Quietly Becoming Business Infrastructure, NOWPayments Data Shows
-
EU okay for winter despite 'historically low' gas stocks: operators
-
Oil surges, stocks sink as US reportedly eyes new Iran strikes
-
Rwanda to host F1 Grand Prix: sources close to both sides
-
Woman in botched US execution walking, mentally 'foggy': lawyer
-
EU top diplomat says bloc in favour of UN Lebanon peacekeepers' extension
-
Farhan hopes Pakistan's new combination takes off in Sri Lanka T20Is
-
Antonelli and Russell to run different Mercedes aero packages in Singapore
-
Teenager Andreeva seals China Open semi-final with Bartunkova
-
WTO hikes 2026 trade growth forecast on AI boom
-
Britain's Burnham says open to Germany joining warplane project
-
'I love that challenge': Hamilton prays for rain in Singapore
-
Kovac's tough love has Dortmund dreaming of title charge
-
G.Bissau moves towards postponement of December general election
-
China announces candidate for WHO chief
-
Verstappen out to settle 'unfinished business' at Singapore Grand Prix
-
South Korea test-fires its first homegrown hypersonic weapon: presidency
-
WhiteBIT Launches Bitcoin Lightning Network Support, Powered by Voltage
-
ONAR Advances Nasdaq Listing Preparation Following Advertise Purple Acquisition and Financing
-
Oil surges, stocks sink as US reportedly eyes fresh Iran strikes
-
Thailand opens extradition process for reporter sought by China
Johnson & Johnson faces UK lawsuit over talc cancer claim
Thousands of UK claimants have filed legal action against US pharmaceutical and cosmetics giant Johnson & Johnson alleging people diagnosed with cancers were exposed to asbestos in its talcum powder, lawyers said Thursday.
The company has faced a series of similar lawsuits in North America, with the latest UK claim filed in the High Court in London.
The law firm representing around 3,000 complainants in Britain said the compensation claim "is estimated to be more than £1 billion" ($1.3 billion).
They allege that either they or a family member developed forms of ovarian cancer or mesothelioma from using J&J's Baby Powder.
"The claim, which covers the period from 1965 to 2023, details how Johnson & Johnson knew that their talc products contained carcinogenic fibres, including asbestos, for more than 50 years," KP Law said.
The company "chose to keep it on the market in the pursuit of profit," it added, claiming J&J only withdrew their mineral talc from Britain in 2023, three years after it was taken off North American shelves.
A Johnson & Johnson spokesperson referred enquiries to its former consumer health arm Kenvue, which it separated from in August 2023.
"As a part of that separation, Kenvue retained the responsibility and any purported liability for talc related litigation outside of the United States and Canada," the spokesperson said.
A Kenvue spokesperson said the safety of J&J's Baby Powder "is backed by years of testing by independent and leading laboratories, universities, and health authorities in the UK and around the world".
The spokesperson added "the high-quality cosmetic grade talc" used in the powder "was compliant with any required regulatory standards, did not contain asbestos, and does not cause cancer".
US courts in April rejected a J&J offer to pay approximately $8 billion over 25 years to settle around 90,000 civil complaints there related to ovarian issues, without admitting liability.
The World Health Organization's cancer agency classified talc as "probably carcinogenic" for humans in July last year.
A summary of studies published in 2020 covering 250,000 women in the United States did not find a statistical link between the use of talc on the genitals and the risk of ovarian cancer.
H.Jarrar--SF-PST